Business Wire News with Multimedia: FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory Epilepsy

Business Wire News with Multimedia News with Multimedia distributed by Business Wire

FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory Epilepsy Feb 26th 2013, 13:00 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--An FDA panel voted unanimously to recommended the RNS System for approval for the treatment of people with medically refractory epilepsy. Media files: ViewMedia?mgid=359611&vid=21 (image/jpeg, 0 MB)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions